8001-97-6
Acne, Atopic Dermatitis, Contact dermatitis and other eczema, Dermatosis, Folliculitis, Intertrigo, Lichen simplex chronicus, Moniliasis, Nummular Dermatitis, Pruritus Ani, Pyoderma, Stasis dermatitis, Disseminated Neurodermatitis, Genital pruritus, Localized Neurodermatitis
Aloe vera (Aloe barbadensis Miller), a succulent plant species, has occupied a significant position in traditional medicine for millennia. Its documented use as a therapeutic agent dates back to ancient civilizations, with records from Sumerian, Egyptian, Greek, and Chinese cultures describing its medicinal applications.[1] Historically, it was employed topically to facilitate wound healing and manage various skin conditions, and orally as a potent laxative.[3] This long-standing history has transitioned into the modern era, where
Aloe vera has become a globally recognized ingredient in a vast array of products, including cosmetics, dietary supplements, functional foods, and beverages.[2]
The plant's therapeutic utility is derived from two chemically and pharmacologically distinct substances produced within its leaves: a clear, viscous inner leaf gel and a bitter, yellow latex found just beneath the plant's rind.[3] The inner gel is prized for its soothing, moisturizing, and anti-inflammatory properties, making it a staple in dermatological and cosmetic formulations. In contrast, the latex, rich in anthraquinone compounds, is known for its powerful stimulant-laxative effects.[6] This fundamental dichotomy is central to understanding the complex and often contradictory scientific literature surrounding
Aloe vera.
This monograph provides a comprehensive analysis of Aloe vera leaf (DB13906), synthesizing current knowledge on its phytochemistry, pharmacology, clinical applications, and safety. A critical finding that permeates this report is the necessity of distinguishing between different Aloe vera preparations. The safety and efficacy profiles of products derived from the purified inner leaf gel are profoundly different from those containing the yellow latex or non-decolorized whole leaf extracts.
The inner leaf gel, rich in polysaccharides such as acemannan, is generally considered safe for topical use and has demonstrated clinical efficacy in treating first- and second-degree burns, psoriasis, radiation-induced dermatitis, and various oral health conditions. Its mechanisms of action are multifaceted, involving potent anti-inflammatory, immunomodulatory, antimicrobial, and wound-healing properties that promote tissue regeneration and integrity.
Conversely, preparations containing aloe latex or non-decolorized whole leaf extract are associated with significant safety concerns. These products contain high concentrations of anthraquinones, primarily aloin, which are responsible for their laxative effects but are also linked to nephrotoxicity and potential carcinogenicity. This has led to divergent regulatory actions globally. In 2002, the U.S. Food and Drug Administration (FDA) banned the use of aloe latex in over-the-counter (OTC) laxative products due to insufficient safety data.[7] Furthermore, the International Agency for Research on Cancer (IARC) has classified non-decolorized whole leaf extract as a Group 2B carcinogen, meaning it is "possibly carcinogenic to humans".[7] In contrast, the European Medicines Agency (EMA) maintains a monograph for the "well-established use" of aloes (dried latex) for the short-term treatment of occasional constipation under strict conditions.[9]
The primary challenge in evaluating the scientific literature and ensuring consumer safety is the pervasive lack of standardization and clear labeling of Aloe vera products. The failure to consistently differentiate between the safe inner gel and the potentially hazardous latex in commercial products and even in some clinical studies has created a landscape of confusion. This report aims to deconstruct this ambiguity by presenting a clear, evidence-based analysis that underscores the importance of chemical composition and processing in determining the ultimate risk-benefit profile of any Aloe vera-derived product.
The substance identified as Aloe vera leaf (DB13906) is derived from the plant Aloe vera (L.) Burm. f. It is known by several botanical synonyms, most commonly Aloe barbadensis Miller and, historically, Aloe vulgaris Lam..[1] While traditionally placed in the lily family (Liliaceae), modern taxonomic systems classify it within the family Xanthorrhoeaceae.[1]
Aloe vera is a perennial, xerophytic (drought-resistant) succulent plant. While it is now cultivated in arid and subtropical regions across the globe, it is believed to be native to Africa.[10] Its characteristic appearance includes thick, fleshy, lance-like leaves that grow in a rosette pattern from a short stem. These leaves serve as the plant's water storage organs, enabling it to survive in harsh, dry environments.[3]
A precise understanding of the Aloe vera leaf's anatomy is fundamental to comprehending its distinct chemical profiles and pharmacological activities. The leaf is composed of three primary layers, each yielding a different substance.[3]
The solid fraction of the Aloe vera leaf contains a remarkably complex array of over 200 different potentially active constituents, which contribute to its diverse therapeutic properties.[15] The chemical profile of a final product is not static; it is highly dependent on the part of the leaf used, the harvesting conditions, and, most critically, the processing methods employed. This variability is a major confounding factor in clinical research and product efficacy. For instance, processing terms like "decolorized whole leaf extract" explicitly refer to filtration steps, often using activated charcoal, designed to remove specific compounds like the color-imparting anthraquinones.[3] Furthermore, the inherent instability of key polysaccharides under heat and the volatility of compounds like acemannan mean that processing techniques such as cold-processing versus heat pasteurization will yield chemically distinct end products.[2] Therefore, a product simply labeled "Aloe Vera Extract" is chemically ambiguous without detailed specifications on its source and processing. The major chemical classes are detailed below.
The most pharmacologically significant components of the inner gel are its polysaccharides. The principal bioactive polysaccharide is acemannan, a long-chain polymer consisting of β-(1,4)-linked glucose and mannose molecules, with mannose being the predominant sugar.[1] Acemannan is highly acetylated, a feature believed to be crucial for its biological activity, particularly its immunomodulatory effects.[6] Other polysaccharides present include pure mannan, acetylated galactan, arabinan, and pectic compounds, which collectively contribute to the gel's hygroscopic (water-binding) and moisturizing properties.[20]
Found almost exclusively in the bitter yellow latex, this class of phenolic compounds is responsible for the plant's well-known laxative effects and is also the primary source of safety concerns. The most abundant of these are the C-glycosides aloin A (also known as barbaloin) and its diastereomer aloin B (isobarbaloin).[2] These compounds are glycosides of
aloe-emodin. The latex also contains free anthraquinones, including aloe-emodin, emodin, and chrysophanol, which exhibit antimicrobial and, in some studies, cytotoxic activities.[8] These compounds can constitute up to 30% of the dry weight of the latex.[4]
Aloe vera contains a variety of chromone derivatives, which are another class of phenolic compounds. The most significant among these are aloesin (formerly aloeresin B), aloeresin A, and isoaloeresin D.[22] Aloesin has been identified as a competitive inhibitor of the enzyme tyrosinase, suggesting a potential role in regulating skin pigmentation.[24]
The following table summarizes the most important bioactive constituents, their location within the leaf, and their primary known activities.
Chemical Class | Key Compound(s) | Primary Location in Leaf | Principal Known Bioactivity |
---|---|---|---|
Polysaccharides | Acemannan, Glucomannan | Inner Gel | Immunomodulation, Wound Healing, Moisturizing |
Anthraquinones | Aloin A (Barbaloin), Aloin B, Aloe-emodin | Latex | Stimulant-Laxative, Antimicrobial, Cytotoxic |
Chromones | Aloesin, Aloeresin A | Latex and Gel | Anti-inflammatory, Tyrosinase Inhibition |
Enzymes | Bradykinase, Catalase | Inner Gel | Anti-inflammatory (topical), Antioxidant |
Vitamins | Vitamin A, Vitamin C, Vitamin E | Inner Gel | Antioxidant, Skin Health |
Minerals | Zinc, Magnesium, Copper | Inner Gel | Enzyme Cofactors, Wound Healing |
This structured chemical profile directly links the plant's distinct anatomical parts to their unique chemical compositions, providing a foundational framework for understanding the divergent pharmacological and toxicological properties discussed in the subsequent sections. It immediately clarifies why the inner gel and the outer latex must be considered as two separate and distinct therapeutic agents.
The extensive array of bioactive compounds within Aloe vera gives rise to a broad spectrum of pharmacological activities. The therapeutic efficacy observed in many applications, particularly in complex processes like wound healing, is likely not due to a single compound but rather a synergistic, multi-target mechanism involving the concerted action of multiple chemical classes. This section details the primary mechanisms of action that underpin its clinical uses.
Aloe vera exhibits potent anti-inflammatory activity through several distinct mechanisms. Topically, the enzyme bradykinase present in the gel helps to break down bradykinin, an inflammatory mediator that induces pain.[2] Systemically, compounds in
Aloe vera inhibit the arachidonic acid pathway by suppressing the cyclooxygenase (COX) enzyme, thereby reducing the synthesis of prostaglandins, which are key drivers of inflammation.[20]
The immunomodulatory effects are largely attributed to the polysaccharide acemannan. Acemannan acts as a potent macrophage-activating agent, stimulating these immune cells to release a cascade of cytokines, including interferon (IFN), tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6).[12] This activation can enhance phagocytosis and antigen presentation, thereby modulating the immune response. Furthermore,
Aloe vera has been shown to suppress the production of pro-inflammatory cytokines such as IL-1β, IL-6, and IL-8, while simultaneously increasing levels of the anti-inflammatory cytokine IL-10, creating a balanced modulatory effect that can quell excessive inflammation.[28] The immunomodulatory response can be dose-dependent, with some evidence suggesting that while certain concentrations are immunostimulatory, others may have immunosuppressive effects, highlighting the complexity of its action.[19]
The efficacy of Aloe vera in promoting the healing of dermal injuries is a result of a coordinated series of actions that address multiple phases of the wound healing process.
Beyond these direct cellular effects, the gel's physical properties are crucial. Its exceptionally high water content (99.5%) and the hygroscopic nature of its polysaccharides provide profound moisturization, which increases skin flexibility, reduces fragility, and prevents the wound from drying out and cracking—creating an optimal moist environment for healing.[13] Additionally, magnesium lactate found in the gel can inhibit the production of histamine from mast cells, which helps to alleviate the itching and irritation commonly associated with healing skin.[29] This combination of anti-inflammatory, proliferative, and moisturizing actions explains its broad utility in treating diverse dermal injuries, from burns to surgical wounds.
Aloe vera possesses broad-spectrum antimicrobial properties, providing a protective barrier against infection in compromised skin. Its activity has been demonstrated against a range of pathogens, including Gram-positive bacteria like Staphylococcus aureus, Gram-negative bacteria such as Pseudomonas aeruginosa and Escherichia coli, fungi like Candida albicans, and enveloped viruses, including Herpes Simplex Virus (HSV) and Influenza virus.[12] This activity is primarily attributed to the anthraquinone compounds, such as aloin and aloe-emodin, found in the latex. These compounds can disrupt microbial cellular processes, inhibiting growth and replication.[2]
The gastrointestinal effects of Aloe vera are sharply divided based on the preparation used.
Emerging research suggests that oral consumption of Aloe vera gel may have beneficial effects on metabolic parameters.
The pharmacokinetic profiles of Aloe vera's constituents are highly variable and depend on their chemical structure, the formulation administered, and interactions within the gastrointestinal tract. A particularly important factor is the role of the gut microbiome, which acts as a critical metabolic organ for bioactivating certain compounds.
The pharmacokinetics of the anthraquinones found in aloe latex are central to both their therapeutic effect and their toxicity. Aloin, the primary ingested compound, is a C-glycoside, a molecular structure that confers relatively poor direct intestinal absorption. In vitro models have shown its absorption to be in the range of 5.5% to 6.6%.[37] The critical step in its pharmacological activation occurs within the colon, where the gut microbiota plays a pivotal role. Specific bacteria possess the necessary glycosidase enzymes to cleave the sugar moiety from the aloin molecule, a process known as deglycosylation. This metabolic transformation releases the aglycone,
aloe-emodin, which is more lipid-soluble and biologically active.[38]
Aloe-emodin itself has a higher absorption rate than its parent glycoside, aloin, with in vitro studies showing absorption between 6.6% and 11.3%.[37] Once absorbed into the bloodstream, both aloin and aloe-emodin undergo extensive phase II metabolism, primarily in the intestinal wall and liver. A significant portion of the absorbed dose is converted into glucuronidated or sulfated conjugates, which are more water-soluble and can be more readily excreted by the body.[37]
This reliance on microbial bioactivation means that the gut microbiome is a critical, non-host factor determining the efficacy and toxicity of oral aloe latex. The composition and metabolic capacity of gut flora vary significantly between individuals. Consequently, two people consuming an identical dose of aloin may experience vastly different outcomes. An individual with a microbiome rich in the specific bacteria capable of efficiently converting aloin to aloe-emodin will have higher levels of the active compound in their colon, leading to a stronger laxative effect and greater systemic exposure to the potentially toxic metabolite. Conversely, an individual whose microbiome lacks this metabolic capacity may experience little to no effect. This microbial variability is a crucial, and often overlooked, factor that contributes to the inconsistent responses observed with oral aloe latex products.
The pharmacokinetic profile of acemannan, the primary polysaccharide in the inner gel, is markedly different from that of the anthraquinones. As a large, complex carbohydrate polymer, its oral bioavailability is presumed to be very low. Its physicochemical properties confirm this; a study determined its partition coefficient (Log P) to be -3.282, indicating that it is highly hydrophilic (water-loving).[18] This characteristic severely limits its ability to passively diffuse across the lipid-rich cell membranes of the intestinal epithelium.
Therefore, when consumed orally, the systemic effects of acemannan are not likely due to the direct absorption of the intact polymer. Instead, its biological activities are mediated through other pathways. Locally, within the gastrointestinal tract, it can exert its effects directly on the gut epithelium, promoting repair, or act as a prebiotic, nourishing beneficial gut flora.[28] Any systemic effects observed following oral consumption are likely indirect. In the colon, acemannan can be fermented by resident microbes into short-chain fatty acids (SCFAs), such as butyrate, propionate, and acetate. These SCFAs are readily absorbed and have their own systemic health benefits, including roles in satiety signaling and metabolic regulation.[39] For acemannan to exert direct systemic immunomodulatory effects, such as the activation of macrophages and dendritic cells via mannose receptor binding, administration would likely need to bypass the gastrointestinal tract, for example, through intravenous injection, to allow for direct contact with circulating immune cells.[39]
An interesting and therapeutically relevant property of Aloe vera gel is its potential to act as a bioavailability enhancer. Several studies suggest that the gel can improve the intestinal absorption and permeation of co-administered drugs that are otherwise poorly absorbable.[2] The exact mechanism for this effect is not fully elucidated but may involve the modulation of tight junctions between intestinal epithelial cells or other interactions that facilitate drug transport across the mucosal barrier. This property could be harnessed to improve the efficacy of various oral medications.
The therapeutic use of Aloe vera has been investigated in numerous clinical trials across various medical disciplines. A significant disconnect exists between the strength of evidence for its topical versus oral applications. The clinical data overwhelmingly support the efficacy of topical Aloe vera gel for a range of localized dermatological conditions, where the risk-benefit profile is highly favorable. In contrast, the evidence for systemic benefits from oral administration is often less conclusive and is complicated by the significant safety concerns associated with certain preparations, particularly those containing the latex.
The application of topical Aloe vera gel for burns and wounds is one of its most well-supported therapeutic uses. A systematic review encompassing 23 clinical trials confirmed its efficacy in treating first- and second-degree burns, various postoperative wounds (including those from episiotomies, cesarean sections, and hemorrhoidectomies), and chronic wounds.[29] In multiple studies on burn wounds,
Aloe vera was found to be more effective than conventional treatments such as 1% silver sulfadiazine ointment and petroleum jelly gauze. A meta-analysis concluded that it could reduce the healing time of first- and second-degree burns by an average of nearly 9 days compared to conventional medication.[29] More recent research from 2022 found that combining
Aloe vera gel with silver sulfadiazine cream significantly enhanced the healing process, reduced itching, and decreased pain compared to controls.[40]
The evidence for Aloe vera in treating psoriasis is mixed, with some systematic reviews noting contradictory results, yet high-quality individual trials have demonstrated significant benefits.[41] A landmark randomized, double-blind clinical trial compared a topical
Aloe vera cream with 0.1% triamcinolone acetonide cream (a moderately potent corticosteroid) in patients with mild to moderate plaque psoriasis. The study found that the Aloe vera cream was statistically more effective than the corticosteroid in reducing the Psoriasis Area and Severity Index (PASI) scores over an 8-week period, indicating a greater reduction in the clinical signs of psoriasis.[26] Based on such evidence, the National Psoriasis Foundation suggests that a cream containing 0.5% aloe may be a useful complementary therapy.[42]
Patients undergoing radiation therapy often suffer from painful skin reactions. A meta-analysis of 14 randomized controlled trials (RCTs) investigated the prophylactic use of Aloe vera. The results showed that pretreatment with topical Aloe vera significantly lowered the overall risk of developing radiation-induced dermatitis and specifically reduced the incidence of more severe (Grade 2 and 3) skin reactions compared to control groups.[40]
Clinical evidence also supports the use of topical Aloe vera for several other skin conditions. In men with genital herpes, a 0.5% aloe extract cream applied three times daily was shown to increase healing rates.[43] For acne, research suggests that applying an aloe gel in conjunction with the prescription retinoid tretinoin improves outcomes by about 35% compared to using tretinoin alone.[5] Furthermore, studies on oral lichen planus, an inflammatory condition of the mouth, have found that applying aloe gel to the lesions can help reduce pain and other symptoms.[5]
The use of aloes, the dried latex from the leaf, for the short-term treatment of occasional constipation is a well-established traditional use. This application is formally recognized by the European Medicines Agency (EMA), which has issued a monograph based on its "well-established use" for this indication.[9] The laxative effect, driven by the anthraquinone compound aloin, is well-documented.[23] However, this is also the application associated with the most significant safety concerns, leading to its removal from the U.S. OTC market.
There is a growing body of evidence suggesting that oral Aloe vera gel may be beneficial for glycemic control. A 2021 systematic review concluded that there is moderate-to-high quality evidence supporting the effects of Aloe vera in patients with prediabetes or type 2 diabetes.[32] This is corroborated by a randomized, double-blind, placebo-controlled trial involving patients with advanced type 2 diabetes. In this study, participants who took a 300 mg capsule of aloe leaf gel twice daily for two months showed statistically significant reductions in both fasting blood glucose and glycosylated hemoglobin (
HbA1c) levels compared to the placebo group, without adverse effects on liver or kidney function.[36]
Aloe vera has demonstrated considerable efficacy in oral hygiene. Multiple clinical studies have found that using an Aloe vera mouthwash is comparable in effectiveness to the gold-standard antiseptic, chlorhexidine, in reducing dental plaque, alleviating gingivitis, and lowering the oral concentration of the cariogenic bacterium Streptococcus mutans.[32]
The application of Aloe vera can accelerate the healing of painful mouth ulcers. A 2022 systematic review of nine RCTs concluded that treatment with Aloe vera (gel or mouthwash) promoted faster healing of aphthous ulcers and offered a shorter healing time compared to other interventions or placebo.[32]
The therapeutic potential of Aloe vera continues to be explored in new areas. A completed clinical trial (NCT03934762) has investigated the use of a topical Aloe vera ointment for improving skeletal muscle recovery after damage.[44] Additionally, DrugBank lists an "Approved for Marketing" status for
Aloe vera leaf for the indication of Liver Disease, although the specific context, product, and jurisdiction for this approval are not detailed in the available materials.[45]
The following table provides a summary of the clinical evidence for the most well-studied applications of Aloe vera.
Medical Condition | Formulation Used | Key Clinical Outcome(s) | Strength of Evidence | Key References |
---|---|---|---|---|
Second-Degree Burns | Topical Gel/Cream | Reduced healing time by ~9 days vs. comparators | High | 29 |
Plaque Psoriasis | Topical 0.5-100% Cream/Gel | Superior reduction in PASI score vs. 0.1% triamcinolone | Moderate | 26 |
Radiation Dermatitis | Topical Gel/Cream (Prophylactic) | Significantly lowered risk and severity of dermatitis | Moderate | 40 |
Type 2 Diabetes | Oral 300 mg Gel Capsule | Significant reduction in fasting glucose and HbA1c | Moderate | 32 |
Occasional Constipation | Oral Latex/Extract | Effective laxative action (short-term use only) | High (Well-Established Use) | 9 |
Dental Plaque/Gingivitis | Mouthwash | Comparable efficacy to chlorhexidine in reducing plaque | Moderate | 32 |
Aphthous Ulcers | Topical Gel/Mouthwash | Accelerated healing time vs. other interventions | Moderate | 32 |
The safety profile of Aloe vera is not uniform; it is critically dependent on the part of the plant used and the method of processing. A clear distinction must be made between the generally safe inner leaf gel and the potentially toxic latex-containing preparations. The global regulatory landscape reflects this complexity, with different agencies adopting divergent approaches based on their assessment of the risk-benefit balance.
The use of certain Aloe vera preparations is contraindicated in specific populations:
Aloe vera can interact with several classes of conventional medications, and these interactions are often specific to the type of aloe preparation used.
There is no global consensus on the risk-benefit analysis of aloe latex, leading to a fragmented regulatory environment. This means that the legality and perceived safety of an aloe laxative product depend entirely on its geographical location and marketing classification (e.g., dietary supplement vs. herbal medicinal product), rather than on a universally accepted scientific standard. The following table details the most clinically significant drug interactions.
Interacting Drug/Class | Aloe Preparation of Concern | Mechanism of Interaction | Clinical Consequence & Recommendation |
---|---|---|---|
Sevoflurane (Anesthetic) | Oral Aloe (unspecified) | Synergistic antiplatelet effects; Aloe reduces prostaglandin synthesis, sevoflurane inhibits thromboxane A2. | Potential for severe intraoperative hemorrhage. Discontinue oral aloe products at least 2 weeks before scheduled surgery. |
Digoxin (Cardiac Glycoside) | Latex / Whole Leaf Extract | Laxative-induced diarrhea leads to potassium loss (hypokalemia). | Hypokalemia sensitizes the myocardium to digoxin, increasing the risk of life-threatening arrhythmias. Concomitant use should be avoided. |
Antidiabetic Agents (e.g., Insulin, Sulfonylureas) | Oral Gel | Additive hypoglycemic effects; Aloe gel can lower blood glucose levels. | Increased risk of hypoglycemia. Patients should monitor blood glucose closely if combining therapies. |
Anticoagulants/Antiplatelets (e.g., Warfarin, Clopidogrel) | Oral Aloe (both Gel and Latex) | Aloe may have intrinsic antiplatelet effects. Latex-induced diarrhea can increase warfarin's INR. | Increased risk of bleeding. Concomitant use requires careful monitoring. |
Diuretics (Thiazide, Loop) | Latex / Whole Leaf Extract | Additive potassium-wasting effects. | Increased risk of severe hypokalemia and electrolyte imbalance. Concomitant use should be avoided. |
General Oral Medications | Latex / Whole Leaf Extract | Laxative effect accelerates gastrointestinal transit time. | Decreased absorption and reduced efficacy of co-administered oral drugs. |
The regulatory status of Aloe vera products is inconsistent globally, reflecting different approaches to risk management.
The dosage and formulation of Aloe vera products vary extensively depending on the intended use, the part of the plant utilized, and the manufacturing process. The lack of standardization, particularly for oral supplements, presents a significant challenge for consumers and clinicians seeking to replicate doses used in clinical trials.
Aloe vera is available in a wide variety of commercial forms:
The widespread use of these concentrates is a double-edged sword. While it facilitates product stability and allows for precise formulation, it also creates significant ambiguity for the end-user. A product label might list "20% Aloe Vera Gel," but this could be formulated by combining just 0.1% of a 200x powder with 19.9% water.[51] Another product might list "0.1% Aloe Vera Powder." To a consumer, these ingredient lists appear vastly different, yet they could contain the exact same amount of active aloe solids. This practice makes it nearly impossible for consumers or clinicians to compare the true "strength" or dose of active ingredients across different products without access to proprietary formulation details.
Dosage recommendations are highly variable and depend on the specific product and indication.
Given the lack of standardization and the potential for toxicity with certain preparations, users should adhere to the manufacturer's recommendations on the product label and consult with a healthcare provider before initiating oral Aloe vera supplementation.
This comprehensive analysis of Aloe vera underscores a fundamental conclusion: Aloe vera cannot be treated as a single, monolithic entity. Its therapeutic value, pharmacological activity, and safety profile are inextricably linked to the specific part of the leaf utilized and the subsequent processing methods. This distinction is the most critical factor in navigating the complex and often contradictory body of scientific and commercial information surrounding this ancient medicinal plant.
The evidence strongly supports the use of purified inner leaf gel as a safe and effective topical agent for a range of dermatological conditions. Its efficacy in accelerating the healing of burns and wounds, alleviating the symptoms of psoriasis, and mitigating radiation-induced dermatitis is backed by numerous clinical trials and systematic reviews. The mechanisms are well-understood, involving a synergistic combination of anti-inflammatory, immunomodulatory, antimicrobial, and profound moisturizing properties.
Conversely, preparations containing the yellow latex or non-decolorized whole leaf extract present a starkly different profile. While their laxative effects are well-established and recognized by some regulatory bodies like the EMA for short-term use, they are associated with significant and well-documented safety risks. These include acute nephrotoxicity, potential carcinogenicity as identified by the NTP and IARC, and a range of clinically significant drug interactions. The decision by the U.S. FDA to remove these preparations from the OTC laxative market reflects a risk-benefit assessment that prioritizes the avoidance of these potential harms. The ambiguity in product labeling and the inconsistent global regulatory landscape create a challenging environment for both clinicians and consumers, making informed decision-making difficult.
Despite thousands of years of use and decades of modern research, significant gaps in our understanding of Aloe vera remain. Addressing these gaps is essential for maximizing its therapeutic potential while ensuring patient safety. Future research should focus on the following key areas:
Published at: September 26, 2025
This report is continuously updated as new research emerges.
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.